Channel for the Professional Oncology & Hematology Communities. Follow us for congress news, interviews & insightful updates. Guidelines:https://t.co/uVFdzxpAc6 InternationalJoined May 2022
From 5-year survival rates of 73% in the mid to late 1970s to 91% today, advancements in breast cancer care are clear. As we mark 40 years of Breast Cancer Awareness Month, progress continues, but early action accelerates it.¹,² Start the conversation about screening!…
#CLL care spans from diagnosis through multiple lines of management and support. How can we ensure continuity across every phase? #BloodCancerAwarenessMonth
When #CLL progresses, many carry unasked questions – such as balancing care, work, and daily life. These may stand in the way of shared decisions. Explore CLL empowerment for information on guidance & support.
e.lilly/3Vtnwrg#WCLLD25#bloodcancer
Supportive care in metastatic #BreastCancer goes far beyond symptom relief—it reflects shifting priorities, emotional needs, and long-term quality of life. How can supportive care strategies better address the different needs and goals of patients at advanced stages?
When #CLL progresses, many carry unasked questions – including their involvement in treatment decisions. These may stand in the way of shared decisions. Explore CLL empowerment for information on guidance & support.
e.lilly/3Vtnwrg#WCLLD25#bloodcancer
Time from the start to end of treatment, also known as time to next treatment (TTNT), offers key insights into #CLL disease control.¹ How does TTNT impact your clinical decisions and patient discussions? #BloodCancerAwarenessMonth
This #BloodCancerAwarenessMonth, we recognize that patients with #CLL value every moment, with keeping the disease from progressing as their top priority.¹,² What other factors are important to patients that might impact adherence to therapy?
Dr. Susanne Pfitzner-Dempfle highlights a rising real-world metric in #HematologicalMalignancy: time to next treatment (TTNT). Why is it valuable and how does it support personalized care? Watch the video to learn more!
When #CLL progresses, many carry unasked questions – like how to support others if their own health declines. These may stand in the way of shared decisions. Explore CLL empowerment for information on guidance & support.
e.lilly/3Vtnwrg#WCLLD25#bloodcancer
Enhancing adherence in #EarlyBreastCancer can be critical for clinical outcomes. How can personalized approaches—such as patient-centered communication and stronger social support—be integrated into clinical care to sustain patient commitment over time?
When #CLL progresses, many carry unasked questions – including what options are available to them. These may stand in the way of shared decisions. Explore CLL empowerment for information on guidance & support.
e.lilly/3Vtnwrg#WCLLD25#bloodcancer
Since #CLL is often incurable, managing expectations becomes vital.¹ How can patient counseling help set realistic goals and support well-being?² #BloodCancerAwarenessMonth
#CLL is a slow-moving blood cancer—but when it progresses, timely action matters.¹ How can we better identify early signs of progression? From subtle lab changes to physical symptoms, recognizing the clues early is key to guiding better care.
Clear, compassionate conversations can help transform care. Dr. Marcelo Pitombeira de Lacerda explores how shared decision-making empowers patients with #HematologicalMalignancy—an approach that reflects Lilly’s deep commitment to patient-centered care.
High BMI can be an underrecognized factor contributing to poor prognosis in patients with #EarlyBreastCancer. As risk stratification tools evolve, how should body composition be integrated into long-term care strategies and intervention planning?
16K Followers 4K FollowingInvestigador ICREA @icreacommunity a @CarrerasIJC, Catedràtic Genètica @UniBarcelona, Director Programa #Epigenètica i Biologia del Càncer
1 Followers 45 FollowingWe are building the first drugless, non-toxic platform to eliminate circulating tumor cells(&more) in real time, redefining cancer therapy.
21 Followers 279 FollowingPassion for 🩺Healthcare Sciences and 🏔️mountains. Mother of 3 👩🦱🧑🦱🧑🦱+🐶. Thriving in chaos💥. Curious💡. All views are my own, RT are not endorsed.
2K Followers 2K FollowingUnapologetically real & resilient. I give what I get but I prefer kindness. #CLL 🧡 Life is messy & beautiful 🦋 take it all in. Free Palestine 🇵🇸
15 Followers 105 FollowingMarmara University Internal Medicine & Department of Medical Oncology - Assoc Prof. Passionate about science, medicine, and innovation
3K Followers 3K FollowingMedical Oncologist @TMH, Passionate for Rare, AYA, Breast cancer , Immunooncology , precision care, travelling n flowers !views are personal!!
1K Followers 2K FollowingVeluwebewoner met de hakken in het zand en heimwee naar Mokum. Oog in oog gestaan met een wild zwijn. Schreef ooit stukjes, wandelt nu en mijmert. Gehuwd.
80K Followers 973 FollowingThe European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
18K Followers 461 FollowingAssociate Professor at @UniGenova & Medical Oncologist at @SanMartino_Ge. Chair of @myESMO YOC. #BreastCancer #Fertility. Big fan of @sampdoria & @giroditalia.
40K Followers 151 Following🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
50K Followers 534 FollowingMedical oncology journal with a specific interest on targeted agents, immune therapies, personalised medicine, molecular pathology, bioinformatics, and more.
144K Followers 1K FollowingUniting caring with discovery to create medicines that make life better worldwide. Lilly’s official account (formerly LillyPad) https://t.co/oXewUD8FZI
6K Followers 606 FollowingDedicated to communicating the latest science & disease state education from Lilly Oncology. Intended for U.S. HCPs. Community Guidelines: https://t.co/1q8vAe63mK
1K Followers 225 FollowingMedical Oncologist, Breast Cancer Unit, Hospital 12 Octubre and HM Hospitales, Madrid. CoChair at SOLTI Group in cancer research. #breastcancer #beSOLTI
2K Followers 4K FollowingChildhood cancer survivor, author & journalist; focused on #ChildhoodCancer; especially late effects; involved in pediatric oncology at @Mayerstiftung
209 Followers 834 FollowingOncologista/Inovação/LaVí Clinical Trials
Startup connecting patients to the best treatments through clinical research - Diversity, agility and tech!
60K Followers 414 FollowingThe Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.
17K Followers 807 FollowingStay Up To Date with our Newsletter: https://t.co/BQxZ2gkon8 Delivering top-quality multimedia to oncologists, hematologists, and cancer pros!
53K Followers 9K FollowingReporting essential clinical news w/ independent analysis for cancer care professionals to optimize patient care & outcomes; oncology/hematology
48K Followers 2K FollowingHealthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
25K Followers 323 FollowingThe Oncologist Journal focuses on medical and practice issues of busy oncology, hematology and radiation professionals to aid in better cancer patient care.
31K Followers 4K FollowingAn interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
5K Followers 206 FollowingOriginal research, reports, opinions, and reviews advancing the science and practice of #precisiononcology. Part of @JCO_ASCO family of journals.
15K Followers 312 FollowingImpactful information & insights to changes & challenges inherent in delivering equitable, high-quality oncology care. Part of @JCO_ASCO family of journals.
13K Followers 269 FollowingCancer care, research and care delivery issues unique to countries and settings with limited healthcare resources. Part of @JCO_ASCO family of journals.
8K Followers 1K FollowingGiuseppe Curigliano, MD, PhD, Professor at University of Milan and Head of Phase I Division at IEO, ESMO Open EiC, Tweets are my own
149K Followers 2K FollowingAccount of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
No recent Favorites. New Favorites will appear here.